Desirae Brinkley
Optometrist · Memphis, TNNPI 1285188490
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Biotissue Holdings Inc. accounts for 63.7% of it on its own, with 25 other manufacturers making up the rest. Among optometrist clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 482 payments — averaging $105.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$32K
- Alcon$5K
- Johnson & Johnson Surgical Vision, Inc.$4K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$3K
- AbbVie$755
- Mallinckrodt Hospital Products Inc.$654
- plus $5K from 20 others
Across 2 payments — averaging $3200.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$3K
- Bausch & Lomb Americas Inc.$3K
What the payments were for
- Consulting fees$23,02845%
- Speaking & faculty fees$3,2006%
- Travel & lodging$7,28814%
- Food & beverage$17,13134%
- Education$2841%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotissue Holdings Inc. | 100 | $32,439 |
| Alcon | 88 | $5,066 |
| Johnson & Johnson Surgical Vision, Inc. | 38 | $3,913 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 43 | $3,008 |
| AbbVie(2 entities) | 33 | $755 |
| Mallinckrodt Hospital Products Inc. | 20 | $654 |
| Bausch & Lomb Americas Inc. | 15 | $604 |
| Harrow Eye, LLC | 17 | $576 |
| Novartis | 23 | $559 |
| Dompe US, Inc. | 11 | $556 |
| Kala Pharmaceuticals, Inc. | 17 | $471 |
| Sight Sciences, Inc. | 12 | $433 |
| Rxsight Inc | 14 | $404 |
| Oyster Point Pharma, Inc. | 14 | $278 |
| Glaukos Corporation | 2 | $277 |
| Sun Pharmaceutical Industries Inc. | 8 | $261 |
| Ivantis, Inc | 8 | $215 |
| Ocular Therapeutix, Inc. | 6 | $170 |
| ANI Pharmaceuticals, Inc. | 3 | $70 |
| Quidel Corporation | 1 | $55 |
| Eyevance Pharmaceuticals LLC | 3 | $51 |
| Thea Pharma Inc. | 2 | $40 |
| Tearlab Corp | 1 | $28 |
| Aerie Pharmaceuticals, Inc. | 1 | $18 |
| Apellis Pharmaceuticals, Inc. | 1 | $15 |
| Carl Zeiss Meditec, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prokera$12,188
- VYZULTA$2,218
- Tecnis Multifocal Family of 1-piece IOLS$1,969
- Tecnis 1-piece IOL$1,850
- Tecnis Symfony IOL$1,850
- AmnioGraft$1,174
- Clareon$751
- Hydrus Microstent$491
- AcrySof IQ PanOptix$370
- Oxervate$343
- VEVYE$312
- Clareon PanOptix Pro$248
- AcrySof IQ PanOptix UV IOL$245
- OMNI(R) SURGICAL SYSTEM (US)$241
- INVELTYS$233
- Tecnis IOL$232
- enVista MX60 IOL$232
- iDose$161
- ORA$145
- PanOptix$144
How this compares
$50,931 in reported general payments places this provider in the 95th percentile of 1,122 optometrist providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 116 | $130,373 |
| RestasisCyclosporine | 90 | $113,407 |
| LumiganBimatoprost | 165 | $81,588 |
| CequaCyclosporine | 51 | $40,552 |
| Cyclosporine | 54 | $35,851 |
| VyzultaLatanoprostene Bunod | 56 | $24,777 |
| VevyeCyclosporine | 17 | $19,060 |
| CombiganBrimonidine Tartrate/Timolol | 44 | $18,067 |
| EysuvisLoteprednol Etabonate | 34 | $17,657 |
| Loteprednol Etabonate | 91 | $16,633 |
| RhopressaNetarsudil Mesylate | 43 | $14,803 |
| RocklatanNetarsudil Mesylat/Latanoprost | 36 | $14,754 |
| Restasis MultidoseCyclosporine | 13 | $10,137 |
| Prednisolone Acetate | 180 | $9,468 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 40 | $8,429 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan, Restasis Multidose, Alphagan P | $755 | $227,240330 claims |
| Bausch & Lomb Americas Inc.Xiidra, Vyzulta | $604 | $155,150172 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $261 | $40,55251 claims |
| Aerie Pharmaceuticals, Inc.Rhopressa, Rocklatan | $18 | $29,55679 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate, Lotemax Sm | $3,008 | $21,861110 claims |
| Harrow Eye, LLCVevye | $576 | $19,06017 claims |
| Kala Pharmaceuticals, Inc.Eysuvis | $471 | $17,65734 claims |
| AlconSimbrinza | $5,066 | $8,42940 claims |
| Eyevance Pharmaceuticals LLCFlarex | $51 | $1,72014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,122 optometrist providers in Tennessee.
Other optometrist in Memphis
- Christopher LievensMemphis$566K
- Whitney HauserMemphis$330K
- Melvin FriedmanMemphis$108K
- Abagail KirkMemphis$14K
- Bradley HinesMemphis$12K
- David EvansMemphis$12K
- Daniel FullerMemphis$8K
- Dennis MathewsMemphis$8K
- Michael GerstnerMemphis$8K
- Laurel RobertsMemphis$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.